Chronic kidney disease (CKD) affects millions of people globally and encompasses a wide variety of underlying causes [3]. While genetic testing has traditionally lagged in nephrology compared to other medical specialties, recent guidelines from organizations like the National Kidney Foundation highlight its growing importance [1, 3]. Understanding how genetics influences kidney health can help patients and clinicians make more informed decisions regarding diagnosis, prognosis, and overall management [1].
The Growing Role of Genetics in Nephrology
Historically, diagnosing kidney disease relied primarily on clinical history, blood tests, imaging, and biopsies. However, genetic factors play a substantial role in many renal conditions [5]. Approximately 10% or more of kidney diseases in adults—and up to 70% of selected chronic kidney cases in children—are estimated to have underlying genetic causes [3]. Inherited disorders and congenital anomalies are particularly prevalent in pediatric populations, whereas adult kidney disease often stems from a mix of genetic susceptibilities and environmental factors [3, 6]. Identifying these genetic roots helps clarify the exact nature of the disease rather than just treating the symptoms [1].
Types of Genetic Tests and Technologies
Nephrology utilizes several advanced testing technologies to scan a patient's DNA for disease-causing alterations. These methods vary in scope and application:
- Targeted Gene Panels: Focus on specific groups of genes known to be associated with particular kidney syndromes or monogenic disorders.
- Exome and Genome Sequencing: Analyze broader sections of DNA to uncover rare or unexpected genetic variants.
- Single Nucleotide Polymorphism (SNP) Arrays: Detect variations across the genome to evaluate genetic risk factors and complex traits [2].
Choosing the right test depends on the patient's specific clinical presentation, family history, and the suspected underlying condition [2, 4].
Clinical Benefits for Diagnosis and Family Planning
Incorporating genetic insights into nephrology practice offers multiple advantages beyond a simple diagnosis [1]. Pinpointing a specific monogenic disorder or high-risk variant (such as APOL1) can inform clinical prognosis, guide therapeutic choices, and assist in transplant planning [1]. Furthermore, genetic results provide critical information for relatives, aiding in family planning and assessing risk in potential living kidney donors who may carry silent genetic traits [1]. Knowing a family's genetic risk profile allows for earlier monitoring and proactive health measures.
Broader Implications and Future Horizons
As genetic tools evolve, their utility extends into wider areas of patient care, including managing CKD-associated comorbidities and utilizing pharmacogenomic tests to optimize medication selection and dosing [2]. Emerging tools like polygenic risk scores may soon offer a more nuanced view of how multiple genes interact with lifestyle and environment to influence kidney function over time [2, 5]. While navigating variant interpretation and ensuring robust informed consent remain complex, genetic testing represents a powerful frontier in personalized nephrology care [2, 4].
Sources
- 1. Incorporating Genetics Into Nephrology Practice-The New National Kidney Foundation Guidelines for Genetic Testing
- 2. Beyond Kidney Genes: Broad Clinical Implications of Genetic Testing for Nephrology Patients
- 3. Advancing Genetic Testing in Kidney Diseases: Report From a National Kidney Foundation Working Group
- 4. Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future
- 5. Genome-wide association studies in nephrology research